YD Bio Ltd cotiza a 6.10 USD y tiene una capitalización bursátil de $432M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes th…
| Métrica | YDES | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 28.1% | 57.0% | -29.0% |
| Operating Margin | -883.3% | -38.6% | -844.7% |
| Net Margin | -1392.6% | -33.6% | -1359.0% |
| FCF Margin | -1346.6% | -13.9% | -1332.7% |
| ROE | — | -40.4% | — |
| ROA | -60.3% | -32.0% | -28.3% |
| Current Ratio | 5.88 | 2.84 | +3.04 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |